10/9/2008 | SS | Shionogi completes $1.1 billion acquisition of Sciele Pharma
|
10/6/2008 | SS | Shionogi begins subsequent offering period for Sciele Pharma
|
9/8/2008 | CV | Sciele says its 2.625% notes are convertible in connection with Shionogi merger
|
9/5/2008 | CV | Market Commentary: AIG, Wachovia reverse losses; Transocean adds; SanDisk climbs on M&A chatter; Schiele Pharma trades
|
9/2/2008 | SS | Market Commentary: Lehman gyrates as KDB may take stake; Alpharma prescribes poison pill
|
9/2/2008 | SS | Sciele Pharma agrees to Shionogi's $31-per-share buyout
|
9/2/2008 | CV | Market Commentary: Chesapeake Energy mixed to slightly better as oil falls; Gilead eases; Sciele gains on buyout bid
|
1/11/2008 | CV | Market Commentary: Countrywide active on BofA buyout; WaMu up on rumored deal; Sciele, Mylan up in search for safety
|
10/17/2007 | CV | Market Commentary: Yahoo! says Yippee; Intel up on earnings; SanDisk rides tech wave; Countrywide down; CIT coming to play
|
6/15/2007 | CV | Sciele: all $150 million of 1.75% notes converted ahead of redemption
|
5/15/2007 | CV | Sciele calls all 1.75% convertibles
|
5/14/2007 | CV | Sciele greenshoe fully exercised to push 2.625% convertibles issue to $325 million
|
5/9/2007 | CV | Market Commentary: Chemed, Sciele soar in debuts; Alesco quiet in gray, Chesapeake draws mixed views; CACI, L-1 plan deals
|
5/9/2007 | CV | New Issue: Sciele prices upsized $285 million 20-year convertibles within talk at 2.625%, up 47.5%
|
5/8/2007 | CV | Sciele talks $250 million 20-year convertibles at 2.375%-2.875%, up 45%-50%, to price Tuesday
|
5/8/2007 | CV | Sciele to redeem 1.75% convertibles with new deal proceeds
|
5/8/2007 | CV | Market Commentary: Armor holds firm on merger hopes; Chemed higher, Sciele quiet in gray; Chesapeake, Alesco launch deals
|
10/27/2006 | BT | RBC: Sciele still at sector perform
|
10/26/2006 | BT | Sciele Pharma ups guidance, ends quarter with $155.3 million of cash
|
9/28/2006 | BT | Sciele announces Ostiva for women at risk for osteoporosis
|
9/26/2006 | BT | RBC keeps Sciele at sector perform
|
9/21/2006 | BKBT | Sciele Pharma $100 million facility priced at Libor plus 175 to 250 bps
|
9/19/2006 | BKBT | Sciele Pharma gets $100 million credit facility
|
8/3/2006 | BT | Sciele adopts new $30 million share repurchase program
|
7/27/2006 | BT | Sciele rated at sector perform by RBC
|
7/26/2006 | BT | Sciele second-quarter revenues up 45% to $72.4 million
|
7/25/2006 | BTCV | Sciele reaches agreement with Nasdaq over rule compliance for exchanged convertible notes
|
6/15/2006 | BT | Board votes to change company name from First Horizon Pharmaceutical to Sciele Pharma
|